Medxy AI

Mapping Liver Cancer’s Hidden Frontiers: NCACC Uncovers Rare cIgG+ Epithelial Cells Driving Tumor Invasion

By MedXY 09/14/2026

NCACC technology identifies rare cIgG+ epithelial cells at liver cancer invasive fronts, revealing a STAT1-dependent signaling axis promoting aggressiveness and offering new therapeutic targets in liver cancer.

Gastroenterology news Oncology

Germline MSH3 and MLH3 Mutations as Tumor Suppressors Elevating Colorectal Cancer Risk via Hypermutation Signature ID4

By MedXY 09/14/2026

Heterozygous germline mutations in MSH3 and likely MLH3 confer an increased colorectal cancer risk through somatic second hits, inducing hypermutant, microsatellite-stable tumors characterized by signature ID4 and excess somatic deletions.

Neurology news

Natural History and Treatment Outcomes in Hemorrhagic Moyamoya Disease: Insights from a Large Chinese Cohort

By MedXY 09/14/2026

A large retrospective study reveals anterior choroidal artery dilation as a key risk for rebleeding in hemorrhagic Moyamoya disease, with indirect revascularization (EDAS) significantly reducing rebleeding and improving outcomes.

Neurology news

Unraveling Bibrachial Amyotrophy in Spontaneous Spinal CSF Leaks: Clinical Insights and Surgical Outcomes

By MedXY 09/14/2026

This study delineates the clinical and radiographic profile of bibrachial amyotrophy (BBA) complicating spontaneous spinal cerebrospinal fluid (CSF) leaks and highlights the potential benefits of early surgical repair within 10 years of symptom onset.

Cardiology Neurology news

Circulating Metabolites as Emerging Biomarkers for Stroke Risk Prediction: Insights from the BiomarCaRE Project

By MedXY 09/14/2026

A large European cohort study identifies six circulating metabolites significantly associated with future stroke risk, highlighting their potential in improving early stroke risk prediction beyond classic risk factors.

Neurology news Radiology

High-Resolution Disconnectome Enhances Prognostic Accuracy and Guides Thrombectomy Decisions in Basilar Artery Occlusion

By MedXY 09/14/2026

This study demonstrates that quantifying disconnected white matter fibers via high-resolution disconnectome analysis predicts 90-day outcomes and identifies thrombectomy responders better than conventional measures in acute basilar artery occlusion.

Neurology news Otorhinolaryngology

Synergistic Impact of Age and Nerve Degeneration on Bell’s Palsy Recovery: Clinical Implications

By MedXY 09/14/2026

Older adults with severe nerve impairment in Bell's palsy experience markedly poorer recovery, highlighting the critical role of early, aggressive intervention.

Diabetes & Endocrinology news

Unraveling Genetic Complexity in Familial Thyroid Follicular Nodular Disease

By MedXY 09/14/2026

This article explores genetic heterogeneity in familial thyroid follicular nodular disease, highlighting key gene variants identified via whole-exome sequencing and the implications for diagnosis and management.

Anesthesiology Critical Care news

Perioperative Code Status Limitations and Early Postoperative Mortality: Insights from a Multicenter Retrospective Cohort Study

By MedXY 09/14/2026

This study investigates the association between continuation of non-full code status during surgery and early postoperative mortality, revealing higher mortality risk that aligns with clinical care decisions rather than missed rescue opportunities.

Diabetes & Endocrinology Gastroenterology news

Genetic Influences on Diabetes Outcomes After Total Pancreatectomy with Islet Autotransplantation

By MedXY 09/14/2026

This study reveals that diabetes-related genetic risk scores predict pre-transplant diabetes status and influence metabolic outcomes one year after total pancreatectomy with islet autotransplantation in chronic pancreatitis patients.

Diabetes & Endocrinology news Ophthalmology

Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes

By MedXY 09/14/2026

A large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, highlighting anti-inflammatory pathways as potential targets for prevention.

news OB/GYN & Women's Health

Impact of Episiotomy Type on Anal Sphincter Injury Risk During Operative Vaginal Delivery in the U.S.

By MedXY 09/14/2026

This study examines how episiotomy type influences the risk of obstetric anal sphincter injury during operative vaginal deliveries, highlighting mediolateral episiotomy's protective effect in women without prior vaginal birth and risks associated with midline episiotomy.

Gastroenterology General Surgery news

Prophylactic Mesh Placement Significantly Reduces Incisional Hernia Risk After Hepatobiliopancreatic Surgery

By MedXY 09/14/2026

A randomized clinical trial demonstrates that synthetic mesh reinforcement during subcostal abdominal closure notably decreases incisional hernia incidence without increasing postoperative complications, improving patient recovery after hepatobiliary surgery.

General Surgery news Oncology

Evaluating Relapse Risks and the Role of Adjuvant Chemotherapy in Localized Appendiceal Adenocarcinoma

By MedXY 09/14/2026

This analysis of localized appendiceal adenocarcinoma reveals low relapse rates post-resection, identifies key histopathologic and molecular relapse predictors, and finds no significant benefit from adjuvant chemotherapy, challenging conventional colorectal cancer treatment paradigms.

Diabetes & Endocrinology Nephrology news

Advancing SGLT Inhibitor Use for Heart and Kidney Protection in Type 1 Diabetes: Opportunities and Challenges

By MedXY 09/14/2026

This article reviews expert perspectives on the efficacy and safety of SGLT inhibitors for cardiovascular and renal disease in type 1 diabetes, outlines translational insights from type 2 diabetes data, and proposes a roadmap for regulatory approval and clinical implementation focusing on surrogate endpoints and diabetic ketoacidosis risk mitigation.

Diabetes & Endocrinology news

β-Cell Dysfunction Enhances Prediction of Type 1 Diabetes Progression in Individuals with Single Autoantibody Positivity

By MedXY 09/14/2026

Assessment of β-cell dysfunction using stimulated glucose and C-peptide measures improves risk stratification for type 1 diabetes progression among single autoantibody-positive relatives, enabling personalized monitoring and targeted interventions.

General Surgery news Oncology

Unveiling Hidden High-Risk Phenotypes in Resected Solid Pseudopapillary Tumors Using Anomaly-Detection Models

By MedXY 09/14/2026

This study employs interpretable anomaly-detection algorithms to identify high-risk phenotypes in resected solid pseudopapillary pancreatic tumors, overcoming limitations of conventional survival models in ultra-rare cancer-specific deaths.

General Surgery news Oncology

Balancing Efficacy and Safety: Neoadjuvant Immunochemoradiotherapy vs. Immunochemotherapy in Elderly Esophageal Squamous Cell Carcinoma

By MedXY 09/14/2026

In elderly patients with locally advanced esophageal squamous cell carcinoma, neoadjuvant immunochemoradiotherapy offers superior tumor response but increases surgical complexity and cardiac risks compared to immunochemotherapy. Personalized treatment decisions are critical.

Cardiology news Respiratory

Distinct Lipid Metabolic Profiles Unveil Pathophysiological Differences Between Postcapillary and Combined Pre- and Postcapillary Pulmonary Hypertension

By MedXY 09/14/2026

This study reveals unique fatty acid and oxylipin metabolic signatures that differentiate isolated postcapillary pulmonary hypertension from combined pre- and postcapillary PH, highlighting potential biomarkers and therapeutic targets.

Cardiology Hematology-Oncology news

Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine Imperative

By MedXY 09/14/2026

Clonal hematopoiesis of indeterminate potential (CHIP) poses a novel cardiovascular risk. This article explores challenges and strategies for designing cardiovascular outcomes trials tailored to CHIP’s genetic heterogeneity and clinical complexity.